• HRP Goat Anti-Mouse IgG (H+L) Antibody: Protocols & QC Guida

  2026-07-27

  The HRP Goat Anti-Mouse IgG (H+L) Antibody (SKU K1221) addresses the need for reliable, high-specificity detection of mouse primary antibodies across Western blot, ELISA, and immunohistochemistry workflows. Researchers should use this affinity-purified, horseradish peroxidase-conjugated reagent where robust signal amplification and enzyme-based detection are essential, but avoid employing it in protocols incompatible with HRP substrates or non-mouse primaries.

• CircHECTD1 Drives Glioblastoma Progression via miR-320-5p/SL

  2026-07-26

  Li et al. uncover a regulatory pathway in glioblastoma where circHECTD1 promotes proliferation and migration by sponging miR-320-5p and upregulating SLC2A1. This molecular mechanism highlights circHECTD1 as a potential therapeutic target, expanding our understanding of noncoding RNA roles in GBM pathogenesis.

• KU-55933: ATM Kinase Inhibition for Next-Gen Personalized Mo

  2026-07-25

  Explore the unique role of KU-55933, a potent ATM kinase inhibitor, in advancing personalized DNA damage response research and iPSC-based disease modeling. Delve into assay design, mechanistic insights, and translational potential beyond existing reviews.

• PARP7 Inhibition Restores STAT1/2 and Ameliorates EAE in Mic

  2026-07-24

  Xu et al. (2025) reveal that PARP7 suppresses type I interferon signaling by promoting autophagic degradation of STAT1/STAT2, leading to worsened neuroinflammation in a mouse model of multiple sclerosis. Pharmacological inhibition of PARP7 stabilizes these transcription factors and significantly alleviates experimental autoimmune encephalomyelitis (EAE), highlighting a promising immunoregulatory target for MS research.

• BI 2536: Driving Translational Precision with Selective PLK1

  2026-07-24

  This article explores how BI 2536, a highly selective PLK1 inhibitor from APExBIO, enables translational researchers to dissect mitotic control, optimize in vitro and in vivo cancer models, and refine mechanistic understanding of cell cycle G2/M arrest and apoptosis. Drawing on recent advances in in vitro drug assessment and mechanistic checkpoint research, it delivers actionable strategy for maximizing experimental rigor and translational relevance.

• Cefoperazone Sodium Salt: Applied Workflows in Antimicrobial

  2026-07-23

  Cefoperazone sodium salt stands out for its robust β-lactamase stability and broad-spectrum efficacy, making it ideal for in vitro antimicrobial activity assays and resistance modeling. This article delivers actionable protocols, troubleshooting strategies, and advanced insights to optimize your bench research using APExBIO's trusted compound.

• Nav1.5 Ser571 Phosphorylation Drives Cardiac Aging Phenotype

  2026-07-23

  This study uncovers how phosphorylation of the cardiac sodium channel Nav1.5 at Ser571 increases late sodium current (INa,L), driving delayed ventricular repolarization and diastolic dysfunction in aging hearts. The findings clarify molecular mechanisms of age-related cardiac decline and suggest late sodium current inhibition as a targeted intervention for arrhythmia prevention research.

• Olaparib (AZD2281): Precise PARP-1/2 Inhibition for Cancer R

  2026-07-22

  Olaparib (AZD2281) is a well-characterized, potent PARP-1/2 inhibitor used for DNA damage response studies and BRCA-associated cancer targeted therapy. Its mechanism exploits homologous recombination repair defects, delivering selective cytotoxicity in BRCA-mutant models. This article reviews molecular rationale, evidence benchmarks, and protocol parameters for translational and preclinical workflows.

• Heterologous Regulation Enhances A40926 and Teicoplanin Yiel

  2026-07-22

  This study investigates how introducing heterologous StrR-like regulatory genes from lipodepsipeptide biosynthetic clusters influences the production of glycopeptide antibiotics, specifically A40926 and teicoplanin. The findings reveal that certain cross-pathway regulators can boost antibiotic yields, presenting new strategies for optimizing biosynthetic output in actinobacteria.

• Linoleic Acid (C18:2) Protocols: Preparation and QC Guidance

  2026-07-21

  Linoleic Acid (C18:2(9Z,12Z); SKU C3108) is a validated reagent for modeling oxidative stress, membrane fluidity, and essential fatty acid deficiency in both cell-based and animal research. It is not suitable for water-based protocols or experiments requiring long-term solution stability, making it essential to follow precise preparation and storage practices for reproducible results.

• NU7441 (KU-57788): Precision DNA-PK Inhibition in Cancer Res

  2026-07-21

  NU7441 (KU-57788) empowers researchers with selective, nanomolar inhibition of DNA-PK, enabling precise interrogation of DNA repair and immune escape mechanisms in oncology. Its high specificity and protocol versatility make it a cornerstone for advanced DNA damage response studies and cell cycle modulation.

• CHI3L1-IN-5 (Compound Z17): Workflow-Driven Neuroinflammatio

  2026-07-20

  CHI3L1-IN-5 (Compound Z17) stands out as a dual-action small molecule for targeted modulation of neuroinflammation and restoration of amyloid-beta clearance in astrocytes. Its optimized pharmacokinetics and CNS penetration, combined with validated inhibition of CHI3L1-mediated NF-κB inflammatory signaling, deliver a robust platform for translational Alzheimer’s disease research.

• Scenario-Driven Strategies with EdU Imaging Kits (HF594)

  2026-07-20

  This article provides an evidence-based, scenario-driven guide for leveraging EdU Imaging Kits (HF594), SKU K2243, to overcome common challenges in cell proliferation and DNA synthesis assays. Drawing from current literature and validated protocols, we highlight the kit’s advantages in sensitivity, workflow integrity, and reproducibility, making it a reliable solution for demanding research workflows.

• Rifampin in Synthetic Biology: Precision Tools for Transcrip

  2026-07-19

  Explore how Rifampin, a rifamycin antibiotic, is revolutionizing transcriptional regulation studies and bacterial resistance mechanism research in synthetic biology. This article delivers advanced, evidence-based insights into its mechanism, assay strategies, and integration with next-generation gene control technologies.

• Actinomycin D in Applied Research: Protocols and Precision T

  2026-07-18

  Actinomycin D (ActD) stands as an essential tool for dissecting transcriptional dynamics, apoptosis induction, and DNA damage response, with unique value in mRNA stability and cancer model assays. This article delivers actionable workflows, troubleshooting strategies, and evidence-based optimizations—bridging recent discoveries in ferroptosis and wound healing with advanced lab applications.

16254 records 1/1084 page Next 12345 下5页 Last page